MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$10,806K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from maturities of mark...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Accretion of discounts on market...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-13,498
-13,722
-17,516
-12,888
Stock-based compensation expense
1,481
1,605
1,043
3,976
Non-cash operating lease expense
-1
58
57
56
Accretion of discounts on marketable securities, net
386
305
511
523
Depreciation and amortization expense
33
38
30
29
In-process research and development, related party
-
-
0
0
Unrealized foreign currency transaction loss
16
-21
5
1
Prepaid expenses and other current assets
-327
-929
706
1,382
Other long-term assets
-304
0
0
162
Accounts payable
200
-1,409
1,792
-393
Accounts payable and accrued liabilities, related party-Related Party
-
-
-
0
Accounts payable and accrued liabilities, related party
-
-
0
-
Accrued expenses and other current liabilities
943
-1,532
220
-792
Operating lease liabilities
67
-62
-39
-59
Long-term liabilities
-
-
0
0
Net cash used in operating activities
-10,546
-14,379
-15,635
-12,139
Purchases of property and equipment
260
-
0
109
Purchases of marketable securities
82,605
44,855
4,996
23,712
Proceeds from maturities of marketable securities
25,602
31,900
30,534
39,081
Issuance of promissory loan in connection with asset acquisition
-
-
0
0
Cash paid in connection with asset acquisition, net of cash received
-
-
0
0
Net cash used in investing activities
-57,263
-12,955
25,538
15,260
Proceeds from exercise of stock options
335
5
65
0
Pre-funded warrant issuance costs
-
-
86
-
Proceeds from issuance of common stock in private placement, net of issuance costs
103,368
-
0
0
Net cash provided by financing activities
103,703
5
-21
0
Effect of exchange rate changes on cash and cash equivalents
0
0
0
0
Net change in cash and cash equivalents
35,894
-27,329
9,882
3,121
Cash and cash equivalents at beginning of period
8,356
35,685
25,803
87,229
Cash and cash equivalents at end of period
44,250
8,356
35,685
25,803
Cash paid for leases included in operating cash outflows
146
-
-
-
Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities
218
-
-
-
Right-of-use assets obtained in exchange for lease liabilities
1,108
-
-
-
Decrease in lease liabilities due to reduction in right-of-use assets from lease modifications
340
-
-
-
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities
280
-
-
-
Cash and cash equivalents
44,107
-
-
-
Restricted cash (included in other non-current assets)
143
-
-
-
Total cash, cash equivalents and restricted cash
44,250
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock in private...
$103,368K
Proceeds from exercise of
stock options
$335K
Net cash provided by
financing activities
$103,703K
Net change in cash
and cash...
$35,894K
(155.61%↑ Y/Y)
Canceled cashflow
$67,809K
Proceeds from maturities
of marketable...
$25,602K
(-38.28%↓ Y/Y)
Stock-based compensation
expense
$1,481K
(-51.20%↓ Y/Y)
Accrued expenses and
other current...
$943K
(-0.11%↓ Y/Y)
Prepaid expenses and
other current assets
-$327K
(74.29%↑ Y/Y)
Other long-term
assets
-$304K
(-122.49%↓ Y/Y)
Accounts payable
$200K
(21.21%↑ Y/Y)
Operating lease
liabilities
$67K
(161.47%↑ Y/Y)
Depreciation and
amortization expense
$33K
(-13.16%↓ Y/Y)
Net cash used in
investing activities
-$57,263K
(-50.83%↓ Y/Y)
Net cash used in
operating activities
-$10,546K
(60.33%↑ Y/Y)
Canceled cashflow
$25,602K
Canceled cashflow
$3,355K
Purchases of marketable
securities
$82,605K
(4.08%↑ Y/Y)
Net loss
-$13,498K
(54.16%↑ Y/Y)
Purchases of property and
equipment
$260K
(237.66%↑ Y/Y)
Accretion of discounts on
marketable securities, net
$386K
(-68.87%↓ Y/Y)
Unrealized foreign
currency transaction...
$16K
(166.67%↑ Y/Y)
Non-cash operating lease
expense
-$1K
(-101.14%↓ Y/Y)
Buy us a coffee
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)